The Breath Biopsy Testing Market Growth Dynamics are currently propelled by the "preventive healthcare" movement. There is a clear transition from treating advanced-stage diseases to identifying them at Stage 0 or I, where survival rates are exponentially higher. This shift is economically favorable for insurance providers, who are now more willing to reimburse non-invasive tests that...